SERATEST ENA(RNP/SM) DETERMINATION

Extractable Antinuclear Antibody, Antigen And Control

SERAGEN DIAGNOSTICS, INC.

The following data is part of a premarket notification filed by Seragen Diagnostics, Inc. with the FDA for Seratest Ena(rnp/sm) Determination.

Pre-market Notification Details

Device IDK844743
510k NumberK844743
Device Name:SERATEST ENA(RNP/SM) DETERMINATION
ClassificationExtractable Antinuclear Antibody, Antigen And Control
Applicant SERAGEN DIAGNOSTICS, INC. P.O. BOX 1210 Indianapolis,  IN  46206
ContactMichael J Sullivan
CorrespondentMichael J Sullivan
SERAGEN DIAGNOSTICS, INC. P.O. BOX 1210 Indianapolis,  IN  46206
Product CodeLLL  
CFR Regulation Number866.5100 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1984-12-05
Decision Date1985-02-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.